drugset / Trial / NCT00457470

A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)

NCT00457470 ↗

Phase 2 Withdrawn Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the safety and efficacy of AG-014699 in diabetic patients

Timeline

Start
2007-06
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped (Enrollment): “Cancelled before first patient enrolled”

Drugs

EvaluationDrugModalityDoseRoute
Subject Rucaparib Small molecule — —